Encorafenib plus binimetinib has won approval from the European Commission for use in patients with BRAF V600E-mutated, advanced non–small lung cancer ...
... Lung Cancer Research Foundation (LCRF). LCRF recognizes an individual whose support of the organization and the field of lung cancer research is ...
No comments:
Post a Comment